About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
C
ENDO 2022: Targeting PCSK9 for LDL-C Reduction
By
Connie Newman
1,816 views
October 5, 2022
1 Comment
Login to view comments.
Click here to Login
Featured Video
04:47
Novartis Cardiology
Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowe…
Featured Video
02:17
Novartis Cardiology
Understanding Acquisition and Billing for a Non-Statin Lipid-Lowerin…
Feat.
B. Buell
Related Content
AUTOPLAY
ON
47:11
Houston Methodist
The Protein Myth: Our Obsession With Protein and How It Is Killing US
Feat.
G. Davis
12:04
Stephen Kopecky
Role of PCSK9 Inhibitors in Diabetes
49:21
Physicians Committee for Responsible Medicine
Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…
Feat.
T. J. Key
34:49
Scripps Health
Medications for Weight Loss: The New Satiety Hormones
Feat.
K. Fujioka
18:43
Canadian Collaborative Research Network
Lp(a): When to Measure it and What to Do About it
Feat.
M. O'Donoghue
59:01
The North American Thrombosis Forum (NATF)
Recent Cholesterol Guidelines and Integration into Clinical Practice
Feat.
J. Plutzky,
L. Braun,
J. Ross
24:02
Complex Coronary Cases
Updated Lipid Guidelines and Therapy
Feat.
I. Fergus
19:24
National Lipid Association
Do Triglycerides Cause Heart Disease?
Feat.
I. Goldberg
08:44
AHA 2022 Conference Coverage
AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…
Feat.
N. Marston
15:06
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
37:21
University of Colorado Department of Medicine
Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…
Feat.
R. Johnson
21:27
Scripps Health
Lipids Update: Current Guidelines for Lipid Management
Feat.
S. R. Mehta
14:50
AHA 2022 Conference Coverage
AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…
Feat.
K. Ray
14:22
Scripps Health
Panel Discussion: Hypertension Management and Coronary Calcium Scori…
Feat.
D. Cork,
C. Mende,
A. Robinson
18:46
Houston Methodist
MAFLD: What Is It?
Feat.
D. Victor
45:45
Houston Methodist DeBakey Heart and Vascular Center
Directions of Cardiology in the Next Decade: 2022-2032
Feat.
E. Braunwald
26:49
Diana Isaacs
Tirzepatide Updates
11:36
Columbia University Institute of Human Nutrition
Rainbow Lentil Soup: Columbia / IHN Breast Cancer Awareness Culinary…
Feat.
O. Weinstein
33:23
Keck School of Medicine of USC
Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…
Feat.
M. Goran
26:32
Practical Ways to Achieve Targets in Diabetes Care
Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity
Feat.
S. Nissen